Niccolò Ravenni, Ph.D, has a diverse work experience in the field of clinical development and operations. Niccolò is currently working as a Project Manager in Clinical Development for Oncology and Immunology at Philogen S.p.A. In this role, they coordinate global clinical development activities for immunocytokines and fusion proteins and interacts with key opinion leaders and clinical development partners. Niccolò also contributes to the design and implementation of product publication strategies and oversees key clinical trial documentation. Prior to this, Niccolò worked as a Clinical Operations Leader at MENARINI Group, where they were responsible for coordinating clinical operations activities for onco-hematology products and managing the clinical trial team. Niccolò also had line-management responsibilities for clinical trial managers and clinical research associates. Before joining MENARINI Group, they worked at Aboca Group as the Head of Clinical Operations and as a Senior Clinical Project Leader. In these roles, they ensured compliance with medical devices regulations and coordinated the clinical development of various therapeutic areas. Additionally, Niccolò has experience in bioanalytics as a Lab Head at Merck Group, where they were responsible for developing and validating immunoassays. Niccolò also managed outsourcing for bioanalytical projects. Furthermore, Niccolò has worked as a Clinical Project Manager at Philogen, overseeing early-phase clinical development trials in rheumatoid arthritis. Niccolò also has experience as a Visiting PhD student and Research Associate at ETH Zurich and as a Research Fellow at the University of Siena.
Niccolò Ravenni Ph.D has a strong educational background in biotechnology. Niccolò obtained their Doctor of Philosophy (PhD) degree in Biotechnology from the Università degli Studi di Siena, which they pursued from 2009 to 2013. Prior to their PhD, they completed their Master of Science (MSc) in Pharmaceutical Biotechnology from the same university, graduating between 2007 and 2009. Niccolò also holds a Bachelor of Science (BSc) degree in Biotechnology from the Università degli Studi di Siena, which they completed from 2004 to 2007.
In addition to their formal education, Niccolò Ravenni has also acquired several certifications to further enhance their skills and knowledge. Niccolò completed a certificate in Developing Business Acumen from LinkedIn in July 2023 and a Mini MBA program from MCE - Management Centre Europe in July 2021. Niccolò also obtained certifications in PhlexEview eTMF from Phlexglobal in February 2020 and Medidata Rave EDC from Medidata Solutions in January 2020. Furthermore, they hold a Digital Training Certificate from Merck Group and an European Computer Driving License from AICA, although the specific months and years of obtaining these certifications are not provided.
Sign up to view 0 direct reports
Get started